Daclizumab exhibits efficacy in multiple sclerosis subjects positive for interferon-beta neutralizing antibodies

被引：0
|
作者：
Neyer, Lauri [1 ]
Singer, Robert [1 ]
Wang, Helen [1 ]
Caras, Ingrid [1 ]
机构：
[1] PDL BioPharma, Preclin & Clin Dev Sci, Redwood City, CA USA
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S169 / S169
页数：1
相关论文
共 50 条
  • [1] Neutralizing Antibodies Against Interferon-Beta in Korean Patients with Multiple Sclerosis
    Hyun, Jae-Won
    Kim, Gayoung
    Kim, Yeseul
    Kong, Byungsoo
    Joung, Aeran
    Park, Na Young
    Jang, Hyunmin
    Shin, Hyun-June
    Kim, Su-Hyun
    Ahn, Suk-Won
    Shin, Ha Young
    Huh, So-Young
    Kim, Woojun
    Park, Min Su
    Kim, Byung-Jo
    Kim, Byoung Joon
    Oh, Jeeyoung
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2018, 14 (02): : 186 - 190
  • [2] Malignant melanoma in a multiple sclerosis patient with persistent neutralizing antibodies to interferon-beta
    Gibbs, E.
    Tremlett, H.
    Ball, N.
    Hashimoto, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (01) : E4 - E4
  • [3] NEUTRALIZING ANTIBODIES AGAINST INTERFERON-BETA IN BULGARIAN ADOLESCENT MULTIPLE SCLEROSIS PATIENTS
    Ivanova, Sonya
    Skrobanska, Raliza
    Kolyovska, Vera
    Milanov, Ivan
    Dimitrova, Valentina
    Bojinova, Veneta
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2018, 71 (09): : 1265 - 1271
  • [4] Interferon-beta specific T cells are associated with the development of neutralizing antibodies in interferon-beta treated multiple sclerosis patients
    Kalluri, Sudhakar Reddy
    Grummel, Verena
    Hracsko, Zsuzsanna
    Pongratz, Viola
    Pernpeintner, Verena
    Gasperi, Christiane
    Buck, Dorothea
    Hemmer, Bernhard
    JOURNAL OF AUTOIMMUNITY, 2018, 88 : 83 - 90
  • [5] Antibodies against interferon-beta in multiple sclerosis
    Aarskog, Nina Karin
    Maroy, Tove
    Myhr, Kjell-Morten
    Vedeler, Christian A.
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 212 (1-2) : 148 - 150
  • [6] Impact of neutralizing antibodies on the clinical efficacy of interferon beta in multiple sclerosis
    Timothy Vartanian
    Per Sölberg Sørensen
    George Rice
    Journal of Neurology, 2004, 251 : ii25 - ii30
  • [7] Impact of neutralizing antibodies on the clinical efficacy of interferon beta in multiple sclerosis
    Vartanian, T
    Sorensen, PS
    Rice, G
    JOURNAL OF NEUROLOGY, 2004, 251 (Suppl 2) : 25 - 30
  • [8] PREVALENCE OF BINDING AND NEUTRALIZING ANTIBODIES AGAINST INTERFERON-BETA IN BULGARIAN MULTIPLE SCLEROSIS COHORT
    Ivanova, Sonya
    Milanov, Ivan
    Kmetska, Ksenia
    Georgiev, Dimitar
    Skrobanska, Raliza
    Dimitrova, Valentina
    Kolyovska, Vera
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2017, 70 (09): : 1315 - 1322
  • [9] Pharmacodynamics of interferon-beta induced mRNA biomarkers in multiple sclerosis patients with neutralizing antibodies
    Ramanathan, M
    Santos, RM
    Zivadinov, R
    Tamaño-Blanco, M
    Justinger, T
    Munschauer, F
    NEUROLOGY, 2006, 66 (05) : A236 - A237
  • [10] Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development
    Hegen, H.
    Millonig, A.
    Bertolotto, A.
    Comabella, M.
    Giovanonni, G.
    Guger, M.
    Hoelzl, M.
    Khalil, M.
    Killestein, J.
    Lindberg, R.
    Malucchi, S.
    Mehling, M.
    Montalban, X.
    Polman, C. H.
    Rudzki, D.
    Schautzer, F.
    Sellebjerg, F.
    Sorensen, P. S.
    Deisenhammer, F.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (05) : 577 - 587
12345